Full Text Available
Note: Clicking the button above will open the full text document at the original institutional repository in a new window.
COVID-19 Rebound in Nirmatrelvir Plus Ritonavir Treatment and Control Groups: Prospective Cohort Study
Saved in:
| Published in: | interactive Journal of Medical Research |
|---|---|
| Format: | Online Article RSS Article |
| Published: |
2026
|
| Subjects: | |
| Tags: |
No Tags, Be the first to tag this record!
|
| _version_ | 1867301678684831749 |
|---|---|
| collection | WordPress RSS FRELIP Feed Integration |
| container_title | interactive Journal of Medical Research |
| description | |
| discipline_display | Health and Safety |
| discipline_facet | Health and Safety |
| format | Online Article RSS Article |
| genre | Journal Article |
| id | rss_article:69491 |
| institution | FRELIP |
| journal_source_facet | interactive Journal of Medical Research |
| publishDate | 2026 |
| publishDateSort | 2026 |
| record_format | rss_article |
| spellingShingle | COVID-19 Rebound in Nirmatrelvir Plus Ritonavir Treatment and Control Groups: Prospective Cohort Study Health and Safety General Health and Safety |
| sub_discipline_display | General |
| sub_discipline_facet | General |
| subject_display | Health and Safety General Health and Safety Health and Safety General Health and Safety |
| subject_facet | Health and Safety General Health and Safety |
| title | COVID-19 Rebound in Nirmatrelvir Plus Ritonavir Treatment and Control Groups: Prospective Cohort Study |
| title_auth | COVID-19 Rebound in Nirmatrelvir Plus Ritonavir Treatment and Control Groups: Prospective Cohort Study |
| title_full | COVID-19 Rebound in Nirmatrelvir Plus Ritonavir Treatment and Control Groups: Prospective Cohort Study |
| title_fullStr | COVID-19 Rebound in Nirmatrelvir Plus Ritonavir Treatment and Control Groups: Prospective Cohort Study |
| title_full_unstemmed | COVID-19 Rebound in Nirmatrelvir Plus Ritonavir Treatment and Control Groups: Prospective Cohort Study |
| title_short | COVID-19 Rebound in Nirmatrelvir Plus Ritonavir Treatment and Control Groups: Prospective Cohort Study |
| title_sort | covid-19 rebound in nirmatrelvir plus ritonavir treatment and control groups: prospective cohort study |
| topic | Health and Safety General Health and Safety |
| url | https://www.i-jmr.org/2026/1/e80263 |